Skip to main content
Back to feed
MarketsSingle-sourceLow
2.1

Oncoclínicas divests 51% stake in Saudi joint venture to Al Faisaliah for US$ 6.55 million

Oncoclínicas has approved a binding offer from Al Faisaliah to sell its remaining 51% stake in their Saudi joint venture, Specialized Medical Treatment Company (SMTC). The transaction provides immediate liquidity to the Brazilian firm and removes future capital expenditure obligations related to the Saudi entity.

Valor Econômicoabout 6 hours agoBR, SACredibility 45%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.5

Intelligence Tags

#divestment#healthcare#joint venture#m&a#liquidity

Locations

Saudi Arabia

Entities

countrycountry
Source

Related signals

8 found